Literature DB >> 19185293

GROMOS96 43a1 performance on the characterization of glycoprotein conformational ensembles through molecular dynamics simulations.

Laercio Pol-Fachin1, Claudia Lemelle Fernandes, Hugo Verli.   

Abstract

Considering the small number of papers assessing the conformational profile of glycoproteins through molecular dynamics (MD) simulations, the current work reports on a systematic analysis of the performance of the GROMOS96 43a1 force field and Löwdin HF/6-31G( * *)-derived atomic charges in the conformational description of glycoproteins. The results substantiate the accuracy of the computational representation of glycoprotein conformational ensembles in aqueous solution based on their agreement to available experimental information, supporting further contributions of computational techniques, mainly MD, in future studies on the characterization of glycoprotein structure and function.

Mesh:

Substances:

Year:  2009        PMID: 19185293     DOI: 10.1016/j.carres.2008.12.025

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  17 in total

1.  Glycosylation is crucial for a proper catalytic site organization in human glucocerebrosidase.

Authors:  Laercio Pol-Fachin; Marina Siebert; Hugo Verli; Maria Luiza Saraiva-Pereira
Journal:  Glycoconj J       Date:  2016-03-29       Impact factor: 2.916

2.  Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.

Authors:  Liang-Chang Hu; Chuan-Hua Ding; Hong-Ying Li; Zhen-Zhen Li; Ying Chen; Li-Peng Li; Wan-Zhong Li; Wen-Shan Liu
Journal:  J Food Biochem       Date:  2022-02-06       Impact factor: 2.720

3.  Shaping up for structural glycomics: a predictive protocol for oligosaccharide conformational analysis applied to N-linked glycans.

Authors:  Benedict M Sattelle; Andrew Almond
Journal:  Carbohydr Res       Date:  2013-10-30       Impact factor: 2.104

4.  Post-translational allosteric activation of the P2X7 receptor through glycosaminoglycan chains of CD44 proteoglycans.

Authors:  Gedd Moura; S V Lucena; M A Lima; F D Nascimento; T F Gesteira; H B Nader; E J Paredes-Gamero; Ils Tersariol
Journal:  Cell Death Discov       Date:  2015-10-05

5.  Picomolar inhibition of β-galactosidase (bovine liver) attributed to loop closure.

Authors:  Jessica B Pickens; Feng Wang; Susanne Striegler
Journal:  Bioorg Med Chem       Date:  2017-07-13       Impact factor: 3.641

6.  The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches.

Authors:  Hong-Lian Li; Ying Ma; Ying Ma; Yu Li; Xiu-Bo Chen; Wei-Li Dong; Run-Ling Wang
Journal:  Oncotarget       Date:  2017-05-16

7.  Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CLpro through high-throughput virtual screening and molecular dynamics simulation.

Authors:  Wen-Shan Liu; Han-Gao Li; Chuan-Hua Ding; Hai-Xia Zhang; Rui-Rui Wang; Jia-Qiu Li
Journal:  Aging (Albany NY)       Date:  2021-03-07       Impact factor: 5.682

8.  Insights into the N-sulfation mechanism: molecular dynamics simulations of the N-sulfotransferase domain of NDST1 and mutants.

Authors:  Tarsis F Gesteira; Laércio Pol-Fachin; Vivien Jane Coulson-Thomas; Marcelo A Lima; Hugo Verli; Helena B Nader
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Discovery of Potential Inhibitors of Squalene Synthase from Traditional Chinese Medicine Based on Virtual Screening and In Vitro Evaluation of Lipid-Lowering Effect.

Authors:  Yankun Chen; Xi Chen; Ganggang Luo; Xu Zhang; Fang Lu; Liansheng Qiao; Wenjing He; Gongyu Li; Yanling Zhang
Journal:  Molecules       Date:  2018-04-28       Impact factor: 4.411

Review 10.  Three-Dimensional Structures of Carbohydrates and Where to Find Them.

Authors:  Sofya I Scherbinina; Philip V Toukach
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.